Azora Therapeutics develops AD04, an investigational treatment for alcohol use disorder and other addiction and related disorders. It last closed at $3.85 on Nov 20, down 0.52% on the day. For the quarter ended Sep 2026, AZR reported EPS of -$4.52. Over the last 12 months AZR insiders bought $106K of stock on the open market and sold $0, according to SEC Form 4 filings.
AI Auto Pilots
Is AZR in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold AZR.
StreetAlpha's call on AZRStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
Whale options flow for AZRHow many large options trades hit AZR, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in AZR in the last 90 days.
From SEC Form 4 filings by AZR's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether AZR is in one of them and how their past AZR trades turned out.
Azora Therapeutics is a clinical stage biopharmaceutical company that develops treatments for addiction and related disorders. Its lead candidate, AD04, is being developed for alcohol use disorder in patients with certain genetic profiles, identified using a companion genetic test. The company's main focus is completing clinical development for AD04 to meet regulatory requirements in the United States and Europe. It has no products approved for sale yet and is based in Encino, California.